Società Jubilant Pharmova Limited

JUBLPHARMA

INE700A01033

Prodotti farmaceutici

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:00:52 03/07/2024			Variaz. 5gg	Var. 1 gen.
735,7 ^INR	-0,37%		+0,06%	+34,81%

18/06	Jubilant Pharmova riceve 15 osservazioni dalla FDA statunitense per l'impianto di produzione dell'unità in Canada; le azioni calano del 3%.	MT
17/06	L'unità Jubilant Pharmova anticipa un prestito a termine di 75 milioni di dollari	MT

Jubilant Pharmova Limited è un'azienda farmaceutica integrata con sede in India. I segmenti dell'azienda comprendono Radiofarma, Immunoterapia delle allergie, Organizzazione di sviluppo e produzione a contratto - Iniettabili sterili, Generici, Organizzazione di ricerca, sviluppo e produzione a contratto, Nuovi farmaci proprietari e Servizi di gestione. Il segmento Radiopharma comprende i radiofarmaci, incluse le radiofarmacie. Il segmento Sviluppo e produzione a contratto - iniettabili sterili comprende prodotti iniettabili sterili a contratto. Il segmento Generici comprende le formulazioni di dosaggio solido. Il segmento Contract Research, Development and Manufacturing Organisation comprende servizi di scoperta di farmaci e ingredienti farmaceutici attivi. Il segmento dei farmaci innovativi proprietari comprende le attività biofarmaceutiche incentrate sul paziente, che lavorano per rispondere alle esigenze mediche insoddisfatte in oncologia e nelle malattie autoimmuni.

Numero di dipendenti: 5 778

INR in Milioni	2022	Peso	2023	Peso	Delta
Radiopharma 40,6 %	-	-	25 524	40,6 %	-
Contract Research, and Development and Manufacturing Organisation 18,9 %	-	-	11 847	18,9 %	-
Contract Development and Manufacturing Organisation - Sterile Injecttables 18,4 %	-	-	11 547	18,4 %	-
Generics 12,1 %	-	-	7 615	12,1 %	-
Allergy Immunotherapy 9,6 %	-	-	6 028	9,6 %	-
Management Services 0,3 %	202	0,3 %	218	0,3 %	+7,69%
Proprietary Novel Drugs 0,1 %	18	0,0 %	38	0,1 %	+107,39%

INR in Milioni	2022	Peso	2023	Peso	Delta
Americas and Europe 89,0 %	53 194	86,8 %	55 935	89,0 %	+5,15%
Rest of the World 7,9 %	4 587	7,5 %	4 976	7,9 %	+8,47%
India 3,0 %	3 394	5,5 %	1 907	3,0 %	-43,83%

Dirigenti	Titolo	Età	Da
Priyavrat Bhartia CEO	Chief Executive Officer	46	23/05/17
Arjun Shanker Bhartia CEO	Chief Executive Officer	37	23/05/17
Arvind Chokhany DFI	Director of Finance/CFO	52	01/04/21
Shyam Sunder Bhartia CHM	Chairman	71	21/06/78
Hari Shankar Bhartia CHM	Chairman	67	01/01/82
Laxshmivarahan Ramasubramani CTO	Chief Tech/Sci/R&D Officer	46	04/05/22
Naresh Kapoor CMP	Compliance Officer	-	01/08/22
Ajay Khanna IRO	Public Communications Contact	63	01/06/09
Shantanu Jha HRO	Human Resources Officer	-	-
Tushar Gupta PRN	Corporate Officer/Principal	-	25/10/21

Amministratori	Titolo	Età	Da
Hari Shankar Bhartia CHM	Chairman	67	01/01/82
Shyam Sunder Bhartia CHM	Chairman	71	21/06/78
Priyavrat Bhartia CEO	Chief Executive Officer	46	23/05/17
Arun Seth BRD	Director/Board Member	72	22/10/18
Sushil Kumar Roongta BRD	Director/Board Member	73	23/05/17
Vivek Mehra BRD	Director/Board Member	69	23/05/17
Arjun Shanker Bhartia CEO	Chief Executive Officer	37	23/05/17
Shirish Gundopant Belapure BRD	Director/Board Member	70	07/03/23
Arvind Chokhany DFI	Director of Finance/CFO	52	01/04/21
R. Kumar BRD	Director/Board Member	60	01/07/22

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	159 281 139	56 058 419 ( 35,19 %)	930 402 ( 0,5841 %)	35,19 %

Nome	Azioni	%	Valorizzazione
SPB Trustee Co. Pvt Ltd. 20,52 %	32 686 161	20,52 %	268 M ₹
HSB Trustee Co. Pvt Ltd. 19,00 %	30 257 475	19,00 %	248 M ₹
East Bridge Capital Management L.P. 7,496 %	11 939 881	7,496 %	98 M ₹
Rekha Rakesh Jhunjhunwala 6,683 %	10 645 000	6,683 %	87 M ₹
Norges Bank Investment Management 3,955 %	6 300 201	3,955 %	52 M ₹
Miller Holdings Pte Ltd. 3,284 %	5 230 455	3,284 %	43 M ₹
Mav Management Advisors LLP 3,146 %	5 011 400	3,146 %	41 M ₹
Nikita Resources Pvt Ltd. 2,200 %	3 504 540	2,200 %	29 M ₹
quant Money Managers Ltd. 1,921 %	3 059 145	1,921 %	25 M ₹
Jubilant Energy Pvt Ltd. 1,328 %	2 116 000	1,328 %	17 M ₹

Nome	Azioni	%	Valorizzazione
JUBILANT INDUSTRIES LIMITED 0.33%	50 000	0.33%	770 415 $

Jubilant Pharmova Ltd.

1A, Sector-16A

201301, Noida

+91 12 0436 1000

http://www.jubilantpharmova.com

Indirizzo Jubilant Pharmova Limited(JUBLPHARMA)

Nome	Categoria e settore
PSI Supply NV PSI Supply NV Drugstore ChainsRetail Trade PSI Supply NV is a Belgian company that supplies and distributes pharmaceutical products. The private company is based in Ghent, Belgium.	Drugstore Chains
Jubilant Biosys Ltd. Jubilant Biosys Ltd. BiotechnologyHealth Technology Jubilant Biosys Ltd. specializes in drug discovery services, proprietary in-house innovation, and strategic investments. Its services include discovery informatics, computational chemistry, structural biology, chemistry, in vitro and in vivo biology, and toxicology. The company was founded by VN Balaji in 2001 and is headquartered in Noida, India.	Biotechnology
Jubilant Pharma NV Jubilant Pharma NV Pharmaceuticals: MajorHealth Technology Part of Jubilant Industries Ltd., Jubilant Pharma NV is a Belgian pharmaceutical company. The company is based in Merelbeke, Belgium. Founded in 2004, Jubilant Pharma operates in the pharmaceutical industry.	Pharmaceuticals: Major
Jubilant Pharmaceuticals NV
Jubilant Pharma Ltd. Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Pharma Ltd. manufactures pharmaceutical products. Its products include solid dosage formulations, radiopharmaceuticals and allergy therapy products. The firm provides contract manufacturing services. The company is headquartered in Singapore.	Pharmaceuticals: Major
Jubilant Clinsys, Inc. Jubilant Clinsys, Inc. Miscellaneous Commercial ServicesCommercial Services Jubilant Clinsys, Inc. offers global clinical trials support operations, clinical development, and phase i-iv clinical trials. The company is headquartered in Yardley, NJ.	Miscellaneous Commercial Services
Jubilant Generics Ltd. Jubilant Generics Ltd. Pharmaceuticals: MajorHealth Technology Jubilant Generics Ltd. engages in the manufacture and export of pharmaceutical products. The company is headquartered in Greater Noida, India.	Pharmaceuticals: Major
TrialStat Solutions, Inc.
Jubilant Pharma Holdings, Inc. Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Jubilant Pharma Holdings, Inc. operates as a pharmaceutical company. The private company is based in Bedminster, NJ.	Pharmaceuticals: Major
Draxis Pharma LLC
Drug Discovery & Development Solutions Ltd. Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore.	Miscellaneous Commercial Services
Jubilant Draximage Usa, Inc. Jubilant Draximage Usa, Inc. Food DistributorsDistribution Services Jubilant Draximage USA, Inc. is an American company that sells and distributes nutrition ingredients and fine chemicals. The private company is based in Spokane.	Food Distributors
JUBILANT INGREVIA LIMITED	Chemicals: Major Diversified
Jubilant Draximage Radiopharmacies Inc.
Jubilant Biosys Innovative Research Services Pte Ltd.
Jubilant HollisterStier Inc.

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
JUBILANT PHARMOVA LIMITED	+34,81%	1,41 Mrd
ELI LILLY AND COMPANY	+55,55%	816 Mrd
NOVO NORDISK A/S	+39,68%	634 Mrd
JOHNSON & JOHNSON	-6,83%	351 Mrd
MERCK & CO., INC.	+17,15%	323 Mrd
ABBVIE INC.	+7,09%	293 Mrd
ASTRAZENECA PLC	+14,06%	238 Mrd
ROCHE HOLDING AG	+1,27%	222 Mrd
NOVARTIS AG	+13,74%	218 Mrd
AMGEN INC.	+7,87%	167 Mrd

Prodotti farmaceutici - Altri